Arcutis Biotherapeutics, Inc.
Pharmaceutical company · Westlake Village, California, United States · Nasdaq: ARQT
Arcutis Biotherapeutics, Inc. is a pharmaceutical company headquartered in Westlake Village, California, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker ARQT. It has reported private securities offerings to the US SEC, most recently $94 million sold in a notice filed in 2019.
Arcutis Biotherapeutics at a glance
What does Arcutis Biotherapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $94.5 million sold (2019).
Frequently asked questions about Arcutis Biotherapeutics
Where is Arcutis Biotherapeutics headquartered?
Arcutis Biotherapeutics, Inc. is headquartered in Westlake Village, California, United States.
What does Arcutis Biotherapeutics do?
Arcutis Biotherapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Arcutis Biotherapeutics a public company?
Yes. Arcutis Biotherapeutics, Inc. trades on Nasdaq under the ticker ARQT.
When was Arcutis Biotherapeutics founded?
The earliest incorporation on record for Arcutis Biotherapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- GENELUX CorpWestlake Village, California, United States
- Sienna Biopharmaceuticals, Inc.Westlake Village, California, United States
- Turn Therapeutics Inc.Westlake Village, California, United States
- Rebus Holdings, Inc.Westlake Village, California, United States
- EOM Pharmaceutical Holdings, Inc.Westlake Village, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences